Overexpression of TRMT12 may independently predict poor overall survival in patients with head and neck squamous cell carcinoma

PURPOSE: The TRMT12 is a novel oncogene involved in breast cancer. However, the association between TRMT12 and head and neck squamous cell carcinoma (HNSCC) remains unclear. MATERIALS AND METHODS: The levels of TRMT12 mRNA in HNSCC and normal tissues were analyzed using data from the Cancer Genome A...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kai, Zheng, Mengmeng, Ren, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733347/
https://www.ncbi.nlm.nih.gov/pubmed/31564910
http://dx.doi.org/10.2147/OTT.S212200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733347/
https://www.ncbi.nlm.nih.gov/pubmed/31564910
http://dx.doi.org/10.2147/OTT.S212200

Ejemplares similares